Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9

BACKGROUND & AIMS: The cancer antigen 19-9 (CA19-9) is the current best biomarker for pancreatic cancer, but it is not increased in approximately 25% of pancreatic cancer patients at a cut-off value that provides a 25% false-positive rate. We hypothesized that antigens related to the CA19-9 anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Huiyuan, Partyka, Katie, Hsueh, Peter, Sinha, Jessica Y., Kletter, Doron, Zeh, Herbert, Huang, Ying, Brand, Randall E., Haab, Brian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792034/
https://www.ncbi.nlm.nih.gov/pubmed/26998508
http://dx.doi.org/10.1016/j.jcmgh.2015.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792034/
https://www.ncbi.nlm.nih.gov/pubmed/26998508
http://dx.doi.org/10.1016/j.jcmgh.2015.12.003

Ejemplares similares